Animal testing for new drugs is being phased out because of advances made in artificial intelligence (AI), the UK’s medicines ...

Multicancer early detection tests hold great promise for finding cancer early enough to save lives, but there are caveats ...

An observational study shows the two factors to be independent predictors of atherosclerotic cardiovascular disease.

The study of predictive processing has become a cornerstone in perception science, aiming to explain how the brain anticipates and interprets sensory ...

Overseas experience suggests predictive tools can improve child protection, if used carefully. Should NZ reconsider its ...

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...

Genetic assays have transformed how clinicians approach treatment decisions in breast cancer, offering both predictive and ...

As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...

New digital platform combines regulatory intelligence, food safety analytics and AI-driven risk detection With SGS ...

Drug developers will be able to use alternatives to animal testing and possibly get new products to market faster under draft guidance issued Wednesday by the FDA. In a press release, officials said ...

Almost all AAV cases were diagnosed in individuals with high pretest probability, including those with renal disease, peripheral neuropathies, or pulmonary infiltrates.